Innovent Biologics
1801.HK
#1221
Rank
A$27.17 B
Marketcap
A$15.58
Share price
-4.74%
Change (1 day)
-12.21%
Change (1 year)

Innovent Biologics (1801.HK) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$4.61 Billion

According to Innovent Biologics's latest financial reports the company's total liabilities are A$4.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Innovent Biologics - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$3.83 B105.41%
2024-12-31A$1.86 B11.13%
2023-12-31A$1.68 B15.09%
2022-12-31A$1.46 B14.17%
2021-12-31A$1.28 B110.12%
2020-12-31A$0.60 B20.42%
2019-12-31A$0.50 B27.78%
2018-12-31A$0.39 B-50.71%
2017-12-31A$0.80 B6.52%
2016-12-31A$0.75 B